JDJin Dai

Jin Dai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jin Dai has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Bibha Dahal

    RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health

    1 shared publication
  • Celia Santos

    RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health

    1 shared publication
  • Cindy Luongo

    RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health

    1 shared publication
  • Emma E. Wiesler

    Department of Biology, 1001 E 3rd Street, Indiana University, Bloomington, IN, USA

    1 shared publication
  • Gail G. Hardy

    Department of Biology, Indiana University , Bloomington , IN 47405

    1 shared publication
  • Kathy F. Zhang

    Department of Biology, Indiana University

    1 shared publication

Latest Publications

  • Open Access

    Intranasal bovine/human parainfluenza virus 3 vaccine candidates expressing human metapneumovirus wild-type or pre-fusion F protein elicit protective immunity against human metapneumovirus in hamsters

    by Sirle Saul, Bibha Dahal, Cindy Luongo, Xueqiao Liu, Lijuan Yang, Celia Santos, Jin Dai, Linong Zhang, Ursula J. Buchholz, Shirin Munir

    Human metapneumovirus (HMPV) and human parainfluenza virus 3 (HPIV3) are among the leading causes of severe pediatric respiratory illness worldwide, and there are no licensed vaccines. Here, we describe live-attenuated pediatric intranasal vaccine candidates for dual protection against HMPV and HPIV3. An attenuated chimeric bovine/HPIV3 (B/HPIV3) based on bovine PIV3, with fusion (F) and hemagglutinin-neuraminidase surface glycoproteins replaced by those of HPIV3, was designed to express HMPV subgroup A F protein, the major protective HMPV antigen. Eight viruses were generated, each containing a different version of the HMPV F ORF, including wild-type (wt), codon-optimized (BBopt or GSopt) to increase protein expression, a chimeric form (GSopt-TMCT) with the transmembrane/cytoplasmic tail (TMCT) sequence replaced with that of BPIV3 F to increase HMPV F packaging, or versions with amino acid substitutions (BBopt-D185P, GSopt-D185P, BBopt-N46V/T160F, and GSopt-N46V/T160F) to improve stability in pre-fusion form and enhance immunogenicity. In hamsters, a single intranasal dose conferred serum HMPV- and HPIV3-neutralizing antibodies and provided protection in the upper and lower respiratory tract against HMPV challenge, similar to that afforded by wt HMPV infection. Control hamsters immunized intramuscularly with two doses of HMPV pre-fusion subunit antigens stabilized by D185P or N46V/T160F mutations developed HMPV-neutralizing antibody titers, similar to those induced by the B/HPIV3/HMPV-F candidates, and were similarly protected against HMPV challenge in the lungs. However, in the upper respiratory tract, B/HPIV3/HMPV-F candidates were significantly more protective than the subunit antigens. Thus, B/HPIV3 expressing HMPV wt or pre-fusion F are promising pediatric vaccine candidates for intranasal immunization against HMPV and HPIV3. IMPORTANCE: Human metapneumovirus (HMPV) and human parainfluenza virus 3 (HPIV3) are important pediatric pathogens and need effective vaccines. We developed live-attenuated chimeric bovine/HPIV3 (B/HPIV3) expressing the fusion (F) protein of HMPV subgroup A as a bivalent pediatric intranasal vaccine against HPIV3 and HMPV. To enhance HMPV F immunogenicity, three approaches were evaluated: codon optimization to increase expression, structure-based mutations to stabilize HMPV F in pre-fusion conformation, or replacement of the HMPV F transmembrane/cytoplasmic domains with those of BPIV3 F to increase incorporation in the virus particle. In hamsters, a single intranasal dose of any of the B/HPIV3s expressing HMPV F was as immunogenic and protective against HMPV as a prior HMPV infection. In the upper respiratory tract, these provided greater protection against HMPV replication than the two intramuscular doses of the adjuvanted HMPV pre-F subunit antigens. B/HPIV3 expressing a codon-optimized pre-fusion stabilized HMPV F was advanced to a pediatric clinical study.


  • Open Access

    ComK-induced cell death is reversed by upregulating the SigB or Spx pathway in Bacillus subtilis

    by Emma E. Wiesler, Qin Liao, Zhongqing Ren, Kathy F. Zhang, Jin Dai, Yinuo Ma, Gail G. Hardy, Xindan Wang

    Natural competence of bacteria is an important tool for researchers to rapidly engineer genetic mutations. In Bacillus subtilis , the master regulator for competence is ComK , which is typically only expressed during stationary phase, allowing cells to uptake DNA and incorporate it into the genome. Here, we engineered cells to overexpress comK in exponential phase using inducible promoters, thereby inducing competence without going through stationary phase. We observed that overexpressing comK in exponentially growing cells inhibited DNA replication and cell division, leading to low DNA content, elongated cells, and eventually cell death. To rescue comK -induced cell death, we isolated suppressors of comK overexpression using both spontaneous suppression and a transposon-based method (transposon sequencing). From both methods, the suppressors upregulated either the sigma B (SigB) or Spx pathway, which are known to be activated in response to stress. Importantly, while upregulating SigB or Spx suppressed cell death, it also reduced competence by lowering ComK protein levels. Altogether, our results collectively show that during competence, normal cellular functions such as DNA replication and cell division are inhibited. While cells can upregulate stress responses to facilitate these normal cellular functions, these processes inadvertently lower ComK levels and inhibit competence. Our study highlights the sophisticated cellular regulatory systems that specifically direct cell growth, competence, or stress management. IMPORTANCE: Naturally competent bacteria, such as Bacillus subtilis, take up DNA to use it as nutrients and generate new genotypes. Researchers exploit natural competence to manipulate bacterial genomes. While all B. subtilis cells in a population are capable of being competent, only a small portion of cells do so. To synchronously induce competence in a cell population, we overexpressed the master competence regulator comK . We found that competence is associated with inhibited cellular functions, such as cell division and DNA replication. Suppressor mutant screens revealed that increasing expression of either stress regulator sigma B or Spx restores cell division and DNA replication functions, but in turn inhibits competence. Our study emphasizes the complex regulatory networks that balance cell growth, competence, and stress responses.